Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Sparsentan Versus Irbesartan in Pediatric Patients With FSGS.
Journal: Kidney international reports
Published: February 04, 2026
Rethinking Proteinuria: Resolution of Donor Derived EXT2-Associated Membranous Nephropathy Following Renal Transplantation.
Journal: Case reports in transplantation
Published: December 26, 2025
Daratumumab for Treatment of Acute Antibody-Mediated Rejection in a Pediatric Kidney Transplant Recipient.
Journal: Pediatric transplantation
Published: April 30, 2025
Noninferiority of Multiplex Polymerase Chain Reaction Compared to Standard Urine Culture for Urinary Tract Infection Diagnosis in Pediatric Patients at Hackensack Meridian Health Children's Hospital Emergency Department.
Journal: Pediatric health, medicine and therapeutics
Published: August 30, 2024
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.
Journal: The New England journal of medicine
Published: November 03, 2023
CMV-associated collapsing focal segmental glomerulosclerosis after kidney transplant in a pediatric patient.
Journal: Pediatric transplantation
Published: December 23, 2022
COL4A gene variants are common in children with hematuria and a family history of kidney disease.
Journal: Pediatric nephrology (Berlin, Germany)
Published: December 20, 2022
The KIDNEYCODE Program: Diagnostic Yield and Clinical Features of Individuals with CKD.
Journal: Kidney360
Published: June 23, 2021
DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS.
Journal: Journal of the American Society of Nephrology : JASN
Published: January 25, 2018
Loss-of-Function Mutations in YY1AP1 Lead to Grange Syndrome and a Fibromuscular Dysplasia-Like Vascular Disease.
Journal: American journal of human genetics
Published: September 21, 2016
Adrenocorticotropic hormone therapy for the treatment of idiopathic nephrotic syndrome in children and young adults: a systematic review of early clinical studies with contemporary relevance.
Journal: Journal of nephrology
Published: January 28, 2016
Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome.
Journal: Kidney international
Published: March 23, 2015
Last Updated: 09/26/2026